Spotlight
Video

ESMO 2012 - PROFILE 1007 Phase 3 Results, Crizotinib, ALK inhibitor

imedex has 1145 videos Subscribe Here

Loading........
Description: ESMO 2012 - PROFILE 1007 Phase 3 Results, Crizotinib, ALK inhibitor - Dr. Pasi A. Janne, MD, PhD of Dana Farber
Shared By : imedex
Posted on : 10/08/12
Added : 5 years ago
Category : General